About Benchling
Founded in 2012, Benchling is a biotech platform designed for biology researchers and research organizations. This cloud-based R&D platform serves as an all-in-one solution for managing experiments, samples, processes, and labs. It aims to make research more accessible and foster greater collaboration among researchers and scientists.
Benchling Industries Press Mentions
Stay in the know about the latest news on Benchling Industries
Investors in Benchling Industries
Discover investors in Benchling Industries stock and explore their portfolio companies
Benchling Industries Management
Leadership team at Benchling Industries
Management Team
Sajith Wickramasekara
Co-Founder & Chief Executive Officer
Ashutosh Singhal
Co-Founder & President
Richard Wong
Chief Financial Officer
Stephen Deasy
Chief Technology Officer
Zach Powers
Chief Information Security Officer
Lindsey Irvine
Chief Marketing Officer
Niall Wall
Chief Partner Officer & Head of Partners
Shawna Wolverton
Chief Product Officer
Board Members
William Griffith
ICONIQ Growth
Register To Buy and Sell Shares
For more details on private stock price information, financing and valuation for Benchling, register or login.
- Benchling's current valuation
- Benchling's stock price
- Explore available deals for Benchling and other companies
- Access deal offering documents
- Pre-Ipomarket's exclusive data and insights, including:
- Cap tables showing funding history by Share Class and Liquidity Preferences
- Key Company Highlights
- Detailed Business Model
- Identified Risk Factors
By registering, you agree to StockMe's Terms of Use. Already registered? Log in
Frequently Asked Questions
How to invest in Benchling shares?
Accredited investors can purchase pre-IPO stock in companies like Benchling through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.
How to sell Benchling shares?
Shareholders have the option to sell their Benchling stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.
Why choose Pre-Ipomarket?
pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."
